High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation.

Non-invasive prenatal testing for fetal rhesus D could substantially reduce unnecessary use of antenatal anti-D, though with a small increase in risk of sensitisation, and may be cost saving.

https://ift.tt/2pPmfvv